GRAIL, Inc. (NASDAQ:GRAL) Position Increased by GAMMA Investing LLC

GAMMA Investing LLC boosted its stake in GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 4,102.5% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,131 shares of the company's stock after purchasing an additional 24,533 shares during the period. GAMMA Investing LLC owned approximately 0.07% of GRAIL worth $642,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Lindbrook Capital LLC acquired a new stake in shares of GRAIL during the fourth quarter valued at about $28,000. State of Tennessee Department of Treasury acquired a new stake in shares of GRAIL during the fourth quarter valued at about $28,000. Sterling Capital Management LLC acquired a new stake in shares of GRAIL during the fourth quarter valued at about $29,000. Wellington Shields Capital Management LLC acquired a new stake in shares of GRAIL during the fourth quarter valued at about $33,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of GRAIL during the fourth quarter valued at about $41,000.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on GRAL shares. Morgan Stanley raised their target price on GRAIL from $16.00 to $20.00 and gave the company an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group raised their target price on GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th.

Insiders Place Their Bets

In other GRAIL news, CEO Robert P. Ragusa sold 94,035 shares of the stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $3,190,607.55. Following the transaction, the chief executive officer now owns 734,627 shares of the company's stock, valued at $24,925,894.11. This trade represents a 11.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Joshua J. Ofman sold 48,213 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total value of $1,635,867.09. Following the completion of the sale, the president now directly owns 511,460 shares in the company, valued at approximately $17,353,837.80. This trade represents a 8.61% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 183,398 shares of company stock valued at $6,222,694 in the last quarter.

GRAIL Stock Down 5.8%

NASDAQ:GRAL traded down $2.81 during trading hours on Friday, reaching $45.63. 2,221,788 shares of the stock were exchanged, compared to its average volume of 1,268,339. The firm has a 50 day simple moving average of $37.25 and a 200-day simple moving average of $31.08. GRAIL, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The stock has a market capitalization of $1.64 billion and a P/E ratio of -0.75.

GRAIL (NASDAQ:GRAL - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. The company had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million. As a group, analysts expect that GRAIL, Inc. will post -15.15 earnings per share for the current year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.